QuantLogix ← BRVE scorecard
📅 BRVE Earnings Preview
BRVE
Next report (est.)
12/07/2026
Countdown
40 days
EPS growth YoY
+0.0%
Revenue growth YoY
+0.0%
Implied vs actual — last 2 reports
ReportOptions impliedActual moveMarket was
09/08/2026 ±9.0% +10.0% under-priced
09/08/2026 ±9.0% +10.0% under-priced
Across these reports, options implied an average ±9.0% move vs an actual average of 10.0% — the stock stayed inside the implied band 0% of the time.
Fundamentals into the print
QuarterEPS (dil.)RevenueNet income
Q2 FY2026 $-2.51 $0 $-15M
Q2 FY2025 — $0 $-14M
Analyst posture
Buy / Strong Buy
10
Hold
1
Sell
0
Strong upward revisions — 14 net (vs 11 prior)
Live 5-factor engine read: Neutral · 56/100 Full scorecard →
🤖 Pro runs a 10-agent AI debate on BRVE before the print — 5 analysts, bull vs bear, a risk read, and a trader's verdict. See Pro →

BRVE (BRVE) reports in 40 days, with the next report estimated for 12/07/2026. Across the last 2 reports, options priced an average ±9.0% earnings move while the stock actually moved 10.0% on average — the market has tended to under-price BRVE's earnings risk. Fundamentals into the print: EPS up 0.0% year-over-year, revenue up 0.0%. QuantLogix's live 5-factor engine currently reads BRVE as a neutral at 56/100.

Implied move is derived from at-the-money option pricing; actual moves are close-to-close on report days. Next-report dates are estimates until confirmed by the company. Educational market analysis, not investment advice. Browse all signal scorecards →